BioSpace News Archive

Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first quarter 2020 financial results after the close of the market on Thursday, May 7, 2020 and hold its investor conference call on the same day, Thursday, May 7, 2020, at 5:00 p.m.

ScholarRx today announced a new partnership with SOMA, the Student Osteopathic Medical Association, which represents the largest network of osteopathic medical students in the United States.

TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that current and new Trial Interactive eTMF customers will have access to free remote and central monitoring solutions to assist study teams during the COVID-19 pandemic.

Standard Motor Products, Inc. (SMP) announces that its Temperature Control Division has delivered heat exchangers suitable for oxygen concentrators and oxygen generators, key components used in the production of medical ventilators.

Evolent Health, Inc. (NYSE: EVH) (“Evolent”), a company providing an integrated value-based care platform to the nation’s leading provider and payer organizations, will release its first quarter 2020 operating results on Thursday, May 7, 2020 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces FDA 510(k) Clearance of its Serranator® PTA Serration Balloon Catheter for treating below-the-knee (BTK) lesions.

New York based Cure Urgent Care has announced that they are the FIRST to offer COVID-19 antibody blood serum testing in NY.

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and production of their biologics, vaccines and gene therapies, announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies.

Siemens Healthineers announced today it is expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 antibodies in blood.

Findings confirmed that patient-specific autologous dendritic cell vaccines (DCV) induced a different immune response associated with longer survival than autologous tumor cell vaccines (TCV) – IRVINE, Calif.--( BUSINESS WIRE )-- AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today the publication of a paper titled, “Cytokine network analysis of immune responses before and after au